Nature Retracts Cancer Study Linking Treatment Timing to Survival

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks

Nature Medicine retracts China lung cancer immunotherapy timing paper, citing data integrity concerns — and the fallout could fuel US anti-China sentiment in biopharma.